183 related articles for article (PubMed ID: 2535720)
1. Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus.
Dewar RL; Natarajan V; Vasudevachari MB; Salzman NP
J Virol; 1989 Jan; 63(1):129-36. PubMed ID: 2535720
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport.
Dewar RL; Vasudevachari MB; Natarajan V; Salzman NP
J Virol; 1989 Jun; 63(6):2452-6. PubMed ID: 2542563
[TBL] [Abstract][Full Text] [Related]
3. High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants.
Chanda PK; Natuk RJ; Mason BB; Bhat BM; Greenberg L; Dheer SK; Molnar-Kimber KL; Mizutani S; Lubeck MD; Davis AR
Virology; 1990 Apr; 175(2):535-47. PubMed ID: 2183470
[TBL] [Abstract][Full Text] [Related]
4. Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160.
Berman PW; Riddle L; Nakamura G; Haffar OK; Nunes WM; Skehel P; Byrn R; Groopman J; Matthews T; Gregory T
J Virol; 1989 Aug; 63(8):3489-98. PubMed ID: 2545918
[TBL] [Abstract][Full Text] [Related]
5. Sulfation of the human immunodeficiency virus envelope glycoprotein.
Bernstein HB; Compans RW
J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500
[TBL] [Abstract][Full Text] [Related]
6. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
Pal R; Hoke GM; Sarngadharan MG
Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446
[TBL] [Abstract][Full Text] [Related]
7. A herpesvirus vector for expression of glycosylated membrane antigens: fusion proteins of pseudorabies virus gIII and human immunodeficiency virus type 1 envelope glycoproteins.
Whealy ME; Baumeister K; Robbins AK; Enquist LW
J Virol; 1988 Nov; 62(11):4185-94. PubMed ID: 2459411
[TBL] [Abstract][Full Text] [Related]
8. Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors.
Paul NL; Marsh M; McKeating JA; Schulz TF; Liljeström P; Garoff H; Weiss RA
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):963-70. PubMed ID: 8280479
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.
Willey RL; Bonifacino JS; Potts BJ; Martin MA; Klausner RD
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9580-4. PubMed ID: 2849111
[TBL] [Abstract][Full Text] [Related]
10. A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations.
Felser JM; Klimkait T; Silver J
Virology; 1989 Jun; 170(2):566-70. PubMed ID: 2543131
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model.
Natuk RJ; Chanda PK; Lubeck MD; Davis AR; Wilhelm J; Hjorth R; Wade MS; Bhat BM; Mizutani S; Lee S
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7777-81. PubMed ID: 1502197
[TBL] [Abstract][Full Text] [Related]
12. Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120.
Thiriart C; Francotte M; Cohen J; Collignon C; Delers A; Kummert S; Molitor C; Gilles D; Roelants P; van Wijnendaele F
J Immunol; 1989 Sep; 143(6):1832-6. PubMed ID: 2476484
[TBL] [Abstract][Full Text] [Related]
13. Processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1 in the presence of trimming glucosidase inhibitor deoxynojirimycin.
Pal R; Kalyanaraman VS; Hoke GM; Sarngadharan MG
Intervirology; 1989; 30(1):27-35. PubMed ID: 2542177
[TBL] [Abstract][Full Text] [Related]
14. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
[TBL] [Abstract][Full Text] [Related]
15. Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines.
Berman PW; Nunes WM; Haffar OK
J Virol; 1988 Sep; 62(9):3135-42. PubMed ID: 2841466
[TBL] [Abstract][Full Text] [Related]
16. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
Rodriguez D; Rodriguez JR; Esteban M
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
[TBL] [Abstract][Full Text] [Related]
17. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
18. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
Freed EO; Martin MA
J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
[TBL] [Abstract][Full Text] [Related]
19. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
Fenouillet E; Jones IM
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
[TBL] [Abstract][Full Text] [Related]
20. Immune response to HIV-1 gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys.
Prevec L; Christie BS; Laurie KE; Bailey MM; Graham FL; Rosenthal KL
J Acquir Immune Defic Syndr (1988); 1991; 4(6):568-76. PubMed ID: 1902514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
